MeSH D018268 - adrenocortical carcinoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| HRA Pharma | Mitotane | Lysodren | 1982-01-01 |
Clinical Trials
Historical Success Rate
Phase 1
43%6/14
Phase 2
15%5/33
Phase 3
18%2/11
Approved: 1Overall Success rate: 1%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use